109 related articles for article (PubMed ID: 21632639)
21. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
[TBL] [Abstract][Full Text] [Related]
22. Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.
Johnston FM; Tan MC; Tan BR; Porembka MR; Brunt EM; Linehan DC; Simon PO; Plambeck-Suess S; Eberlein TJ; Hellstrom KE; Hellstrom I; Hawkins WG; Goedegebuure P
Clin Cancer Res; 2009 Nov; 15(21):6511-8. PubMed ID: 19843662
[TBL] [Abstract][Full Text] [Related]
23. [The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9].
Liu HD; Yan Y; Cao XF; Tan PZ; Wen HX; Lv CM; Li XM; Liu GY
Sheng Li Xue Bao; 2010 Dec; 62(6):524-8. PubMed ID: 21170498
[TBL] [Abstract][Full Text] [Related]
24. The epithelial-mesenchymal transition induces aggressivity of mucinous cystic neoplasm of the pancreas with neuroendocrine component: An immunohistochemistry study.
Gurzu S; Bara T; Molnar C; Bara T; Butiurca V; Beres H; Savoji S; Jung I
Pathol Res Pract; 2019 Jan; 215(1):82-89. PubMed ID: 30391209
[TBL] [Abstract][Full Text] [Related]
25. Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with ⁸⁹Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.
ter Weele EJ; Terwisscha van Scheltinga AG; Kosterink JG; Pot L; Vedelaar SR; Lamberts LE; Williams SP; Lub-de Hooge MN; de Vries EG
Oncotarget; 2015 Dec; 6(39):42081-90. PubMed ID: 26536664
[TBL] [Abstract][Full Text] [Related]
26. Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers.
Sharon E; Zhang J; Hollevoet K; Steinberg SM; Pastan I; Onda M; Gaedcke J; Ghadimi BM; Ried T; Hassan R
Clin Chem Lab Med; 2012 Apr; 50(4):721-5. PubMed ID: 22149739
[TBL] [Abstract][Full Text] [Related]
27. AKR1B10 expression by immunohistochemistry in surgical resections and fine needle aspiration cytology material in patients with cystic pancreatic lesions; potential for improved nonoperative diagnosis.
Connor JP; Esbona K; Matkowskyj KA
Hum Pathol; 2017 Dec; 70():77-83. PubMed ID: 29079172
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of various clones of estrogen receptor in cell block preparation of lung adenocarcinoma.
Hakima L; Schlesinger K; Sunkara J; Karabakhtsian RG
Diagn Cytopathol; 2018 May; 46(5):390-394. PubMed ID: 29465823
[TBL] [Abstract][Full Text] [Related]
29. Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.
Liu H; Shi J; Anandan V; Wang HL; Diehl D; Blansfield J; Gerhard G; Lin F
Arch Pathol Lab Med; 2012 Jun; 136(6):601-9. PubMed ID: 22646265
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic metastases of renal clear cell carcinoma: a clinicopathological study of 11 cases with special emphasis on the usefulness of PAX2 and mesothelin for the distinction from primary ductal adenocarcinoma of the pancreas.
Gnemmi V; Leroy X; Triboulet JP; Pruvot FR; Villers A; Leteurtre E; Buob D
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):157-62. PubMed ID: 24344503
[TBL] [Abstract][Full Text] [Related]
31. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
32. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S
J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735
[TBL] [Abstract][Full Text] [Related]
33. The correlation between GPR30 and clinicopathologic variables in breast carcinomas.
Tu G; Hu D; Yang G; Yu T
Technol Cancer Res Treat; 2009 Jun; 8(3):231-4. PubMed ID: 19445541
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma.
Lau SK; Chu PG; Weiss LM
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):83-7. PubMed ID: 16540736
[TBL] [Abstract][Full Text] [Related]
35. Metastatic adenocarcinoma to the brain: an immunohistochemical approach.
Perry A; Parisi JE; Kurtin PJ
Hum Pathol; 1997 Aug; 28(8):938-43. PubMed ID: 9269830
[TBL] [Abstract][Full Text] [Related]
36. Cytologic evaluation of prognostic markers in breast carcinoma.
Jayaram G; Elsayed EM
Acta Cytol; 2005; 49(6):605-10. PubMed ID: 16450899
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
[TBL] [Abstract][Full Text] [Related]
38. Use of IMP3 in identification of carcinoma in fine needle aspiration biopsies of pancreas.
Yantiss RK; Cosar E; Fischer AH
Acta Cytol; 2008; 52(2):133-8. PubMed ID: 18499984
[TBL] [Abstract][Full Text] [Related]
39. Aberrant Expression of Calretinin, D2-40 and Mesothelin in Mucinous and Non-Mucinous Colorectal Carcinomas and Relation to Clinicopathological Features and Prognosis.
Foda AA; El-Hawary AK; Hamed H
Pathol Oncol Res; 2016 Oct; 22(4):725-32. PubMed ID: 27062033
[TBL] [Abstract][Full Text] [Related]
40. Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
Frierson HF; Moskaluk CA; Powell SM; Zhang H; Cerilli LA; Stoler MH; Cathro H; Hampton GM
Hum Pathol; 2003 Jun; 34(6):605-9. PubMed ID: 12827615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
